BridgeMD
Tests treatment safety and results for Stroke
Official title Efficacy of Rehabilitation Using Action Observation and Muscle Stimulation in Post-stroke Patients.
ClinicalTrials.gov ID: NCT06055569
What this study is testing
- What it's testing
- Stroke is the third most common cause of disability worldwide and leads to upper limb motor disease in more than half of people affected. Recent data demonstrate that upper limb rehabilitation can be pursued using techniques such as the observation of action (Action Observation Therapy - AOT) or the stimulation of limb musculature using surface electrodes (Neuromuscular Electrical Stimulation - NMES).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age over 18 years;
- Upper arm motor impairment after unilateral stroke as verified by MRI or CT;
- Two weeks up to 6 months after stroke;
- Grading of upper arm motor impairment\>2 at Medical Research Council scale (MRC).
You likely can't join if
- Neurological/orthopedic issues that would interfere with upper limb exercises;
- Presence of any medical condition that represents a contraindication to Magnetic Resonance Imaging (MRI) examination or to Transcranial Magnetic...
- Presence of dermatologic issues that will interfere with neuromuscular stimulator;
- Presence of electronic subcutaneous implants;
- Presence of peripheral neuropathy;
- Epilepsy;
See the full eligibility criteria
- Age over 18 years;
- Upper arm motor impairment after unilateral stroke as verified by MRI or CT;
- Two weeks up to 6 months after stroke;
- Grading of upper arm motor impairment\>2 at Medical Research Council scale (MRC).
- Neurological/orthopedic issues that would interfere with upper limb exercises;
- Presence of any medical condition that represents a contraindication to Magnetic Resonance Imaging (MRI) examination or to Transcranial Magnetic Stimulation (TMS);
- Presence of dermatologic issues that will interfere with neuromuscular stimulator;
- Presence of electronic subcutaneous implants;
- Presence of peripheral neuropathy;
- Epilepsy;
- Pregnancy;
- Presence of severe cognitive impairment, including language comprehension detected during the neurological evaluation.
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italia, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.